MoS calls for strengthening India-Italy collaborative research for innovation (See 'Corp Brief') Ministry of Culture invites Partners to Build India's Creative Economy Together (See 'Corp Brief') DoT organises First All India Conference on Official Language 2026 in New Delhi (See 'Corp Brief') Centre strengthens healthcare network through 3 Urban Primary Health Centres (See 'Corp Brief') TDB-DST signs agreement with Astrome to develop sovereign space-based AI-ELINT constellation (See 'Corp Brief') 2nd Edition of the National Tribal Literary Festival 2026 begins in New Delhi (See 'Corp Brief') CCRAS-CARI and University of Delhi sign MoU to document medicinal plant diversity (See 'Corp Brief') RTI - Per Sections 2 & 3 of the Act, CPIO is not obligated to compile, analyze, correlate, or generate fresh datasets from disparate records in specific format desired by applicant: IBBI (See 'Legal Desk') Naturopathy Day 2026: Scientific Research strengthens India's Nature-Based Healthcare Ecosystem (See 'Corp Brief') India and Italy to deepen scientific cooperation through bilateral engagements (See 'Corp Brief') Yadav holds interaction with LeadIT Industry Members and Project Partners (See 'Corp Brief') SEBI - Stay on 5-year debarrment unwarranted where Appellant fails to make out prima facie case - unusual trading pattern noted along with admitted receipt of certain funds from connected entities: SAT (See 'Legal Desk') India strengthens Regional Health Partnerships as First BIMSTEC summit (See 'Corp Brief') CBN dismantles clan lab of mephedrone in Uttar Pradesh (See 'Corp Brief') IPR - Dominant element of composite mark is entitled to standalone protection and party cannot resile from concession made on court record without seeking formal recall of order: HC (See 'Legal Desk') NHAI debars Bijwasan User Fee Collection Agency for One Month (See 'Corp Brief') BEE organises Webinar during BRICS Sustainable Lifestyle Week 2026 (See 'Corp Brief') RTI - Once information held by the public authority is duly disclosed or pointed out, the public authority is under no legal obligation to create, compile, or separately furnish new information: IBBI (See 'Legal Desk') Bharat Mobility Expo to be second largest such expo in the world: Goyal (See 'Corp Brief') MY Bharat organises Nationwide Deepotsav and Neighbourhood Youth Parliaments (See 'Corp Brief') India's Deep-Sea Exploration Is Advancing with MATSYA-6000 and Indo-French Collaboration: MoS (See 'Corp Brief') Round 2 for Surface Coal, Lignite Gasification Projects concludes with 2 Applications from NTPC (See 'Corp Brief') DRI recovers two elephant tusks weighing 3.7 kg (See 'Corp Brief') Govt holds Round Table with CPSEs on Enhancing Procurement from SC/ST MSEs (See 'Corp Brief') SARFAESI - Authority must verify statutory declarations & supporting material & on being satisfied that prescribed requirements are fulfilled, must pass appropriate orders for taking possession of secured asset - cannot adjudicate disputed questions falling beyond limited scope of Section 14: HC (See 'Legal Desk') Special Campaign: Waste Disposal generates revenue of Rs 15.74 Crores (See 'Corp Brief') IBC - Provisions of IBBI (Insolvency Resolution Process for Corporate Persons) Regulations, 2016 contravened where RP unilaterally withdraws higher monthly fee without prior approval of CoC: IBBI (See 'Legal Desk') Delhi Railway Area handles 5 Lakh Passengers Daily - Footfall rises to 8 Lakh during festivals (See 'Corp Brief') IBC- SC exercises power under Article 142 - Borrower firm to pay further sum of 125 crores rupees as full & final settlement of all claims concerning assigned debt: SC LB (See 'Legal Desk') Legislative Department initiates Interaction Series on Personal Effectiveness in Leadership (See 'Corp Brief') National Exercise strengthens India's Preparedness for Foot-and-Mouth Disease (See 'Corp Brief') IBC - Once existence of financial debt & a default is clearly established through unimpeachable evidence & records from information utility, admission of application u/s 7 is mandatory: NCLAT (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.